|
Market Closed -
Nasdaq
07:00:00 20/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 153.07 USD | -2.00% |
|
+1.75% | +24.71% |
| 19/10 | Gilead's pill succeeds in mid-stage bowel disease trial | RE |
| 17/10 | Gilead Sciences Insider Sold Shares Worth $468,660, According to a Recent SEC Filing | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2.00% | +1.75% | +1.97% | +13.99% | +24.71% | +24.64% | +95.14% | +128.80% | +108.71% | 194B | |
| -1.33% | +4.88% | +7.58% | +5.19% | +15.41% | +54.50% | +109.94% | +411.88% | +1,478.84% | 1,120B | |
| -0.69% | -3.77% | -6.00% | +0.30% | +22.63% | +31.35% | +66.62% | +54.87% | +121.48% | 616B | |
| -0.96% | +0.55% | +7.09% | +11.08% | +23.72% | +23.13% | +94.26% | +163.08% | +360.17% | 504B | |
| +0.24% | +5.58% | +6.53% | +13.73% | +15.81% | +33.98% | +59.40% | +6.19% | +62.57% | 367B | |
| -1.59% | -1.25% | -2.21% | +12.65% | +36.45% | +69.39% | +43.02% | +80.69% | +132.15% | 360B | |
| -0.40% | +3.53% | +7.91% | -0.64% | +13.32% | +19.17% | +46.55% | +61.95% | +65.82% | 288B | |
| -0.37% | +3.11% | -0.80% | -1.54% | -10.08% | -1.26% | +18.23% | +41.89% | +150.99% | 258B | |
| -1.75% | +1.76% | +10.19% | +16.01% | +29.83% | +42.21% | +51.44% | +105.50% | +163.81% | 234B | |
| -1.19% | +0.04% | -8.90% | -22.25% | -21.14% | -25.14% | -62.51% | -23.43% | +85.67% | 173B | |
| -0.47% | +3.66% | +6.44% | +17.52% | +18.23% | +20.11% | -5.61% | -30.05% | -9.69% | 169B | |
| +0.44% | -1.00% | -1.26% | +3.36% | +10.72% | +20.43% | +37.60% | +170.72% | +513.41% | 127B | |
| -1.54% | +2.17% | -6.71% | -3.14% | +9.07% | +34.84% | +4.16% | +2.15% | +17.97% | 122B | |
| +0.56% | +5.72% | +15.52% | +20.09% | +23.18% | +28.55% | +122.92% | +398.76% | +527.13% | 117B | |
| -0.40% | +4.74% | -1.20% | -3.21% | +1.67% | +14.15% | +27.83% | +5.46% | -10.87% | 99.56B | |
| -1.29% | -0.82% | -4.11% | -8.18% | -14.16% | -17.84% | -28.13% | -14.06% | +3.63% | 96.96B | |
| +4.07% | +6.15% | +47.29% | +267.02% | +669.38% | +772.32% | +175.45% | -31.99% | - | 87.04B | |
| -1.10% | +2.52% | -0.36% | +15.57% | +1.32% | +35.29% | -3.29% | +41.65% | +112.30% | 78.96B | |
| +0.03% | +4.11% | +11.17% | +5.91% | +17.74% | +28.65% | -3.80% | -25.99% | +46.12% | 70.58B | |
| +0.62% | +3.23% | -4.23% | -13.90% | -22.73% | -9.80% | +40.04% | +60.51% | +432.23% | 66.2B | |
| Average | -0.62% | +2.76% | +4.30% | +17.48% | +43.25% | +59.93% | +44.46% | +80.43% | +229.60% | 257.37B | |
| Weighted average by Cap. | -0.85% | +2.54% | +3.75% | +9.99% | +26.54% | +44.61% | +62.74% | +145.40% | +451.22% |
- Stock Market
- Stocks
- GILD Stock
- Sector Gilead Sciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
